Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141047 |
| CAS No | NA |
| Mol.F. | C28H53N9O |
| Mol.Wt. | 531.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141048 |
| CAS No | NA |
| Mol.F. | C10H23N5O |
| Mol.Wt. | 229.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141049 |
| CAS No | NA |
| Mol.F. | C31H41N5O7S3 |
| Mol.Wt. | 691.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141050 |
| CAS No | NA |
| Mol.F. | C11H14ClN7O2 |
| Mol.Wt. | 311.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141051 |
| CAS No | NA |
| Mol.F. | C11H15ClN6O |
| Mol.Wt. | 282.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141052 |
| CAS No | NA |
| Mol.F. | C11H15ClN6O |
| Mol.Wt. | 282.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141053 |
| CAS No | NA |
| Mol.F. | C17H30ClN3O6S |
| Mol.Wt. | 440.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141054 |
| CAS No | NA |
| Mol.F. | C18H32ClN3O6S |
| Mol.Wt. | 454.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141055 |
| CAS No | NA |
| Mol.F. | C13H13FN4O2 |
| Mol.Wt. | 276.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141056 |
| CAS No | NA |
| Mol.F. | C21H14F4N6O3S |
| Mol.Wt. | 506.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141057 |
| CAS No | NA |
| Mol.F. | C8H8FN3O2 |
| Mol.Wt. | 197.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141058 |
| CAS No | NA |
| Mol.F. | C7H3F3N4O |
| Mol.Wt. | 216.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141059 |
| CAS No | NA |
| Mol.F. | C13H14FN3O4 |
| Mol.Wt. | 295.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141060 |
| CAS No | NA |
| Mol.F. | C16H16N6O9S2 |
| Mol.Wt. | 500.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141061 |
| CAS No | NA |
| Mol.F. | C15H16N6O7S2 |
| Mol.Wt. | 456.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141062 |
| CAS No | NA |
| Mol.F. | C16H14N6O8S2 |
| Mol.Wt. | 482.4 |
| INV STATUS | CUSTOM SYNTHESIS |